These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 213623)

  • 1. Serum high density lipoprotein in hemodialysis patients.
    Unoki T
    Jpn Circ J; 1978 Jul; 42(7):855-64. PubMed ID: 213623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on a dyslipoproteinemia in hemodialysis patients.
    Handa Y
    Jpn Heart J; 1978 Mar; 19(2):236-51. PubMed ID: 206740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cholesterol binding reserve and high density lipoprotein cholesterol in patients on maintenance hemodialysis.
    Perez GO; Hsia SL; Christakis G; Burr J
    Horm Metab Res; 1980 Sep; 12(9):449-54. PubMed ID: 7429416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
    Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
    Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effects of hemodialysis on plasma lipoproteins.
    Wada M; Minamisono T; Fujii H; Morita T; Akamatsu A
    Trans Am Soc Artif Intern Organs; 1975; 21():464-72. PubMed ID: 167493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.
    Chan MK; Persaud J; Varghese Z; Moorhead JF
    Kidney Int; 1984 May; 25(5):812-8. PubMed ID: 6471667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
    Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
    Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of serum lipid abnormalities in chronic hemodialysis.
    Brunzell JD; Albers JJ; Haas LB; Goldberg AP; Agadoa L; Sherrard DJ
    Metabolism; 1977 Aug; 26(8):903-10. PubMed ID: 195181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
    Singh A; Tejani A
    Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
    Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
    J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein spectrum analysis of uremic patients maintained on chronic hemodialysis.
    Felts JM; Zacherle B; Childress G
    Clin Chim Acta; 1979 Apr; 93(1):127-34. PubMed ID: 219971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients.
    Barbagallo CM; Noto D; Cefalù AB; Ganci A; Giammarresi C; Panno D; Cusumano G; Greco M; Di Gaudio F; Averna MR
    Hemodial Int; 2015 Jul; 19(3):360-7. PubMed ID: 25495659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.
    Jia L; Fu M; Tian Y; Xu Y; Gou L; Tian H; Tian L
    Int J Cardiol; 2007 Sep; 120(3):331-7. PubMed ID: 17166608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol content of serum lipoprotein fractions in children maintained on chronic hemodialysis.
    Gambert P; Lallemant C; Andre JL; Athias A; Bourquard R; Pierson M; Padieu P
    Clin Chim Acta; 1981 Mar; 110(2-3):295-300. PubMed ID: 7226533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic lipoproteins in end-stage renal disease.
    Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S30-3. PubMed ID: 11576918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.